First Horizon Advisors, Inc. Amgen Inc Transaction History

First Horizon Advisors, Inc.

$3.58 Billion
Q3 2024

A detailed history of First Horizon Advisors, Inc. transactions in Amgen Inc stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 60,769 shares of AMGN stock, worth $17.9 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares

60,769

Previous 58,897 3.18%

Holding current value

$17.9 Million

Previous $18.4 Million 6.4%

% of portfolio

0.55%

Previous 0.56%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$309.38 - $337.38 $579,159 - $631,575	1,872 Added 3.18%	60,769 $19.6 Million
Q2 2024 Jul 19, 2024	BUY	$262.75 - $319.31 $109,304 - $132,832	416 Added 0.71%	58,897 $18.4 Million
Q1 2024 Apr 26, 2024	BUY	$268.87 - $324.56 $4.62 Million - $5.58 Million	17,182 Added 41.6%	58,481 $16.6 Million
Q4 2023 Feb 06, 2024	SELL	$255.7 - $288.46 $254,421 - $287,017	-995 Reduced 2.35%	41,299 $11.9 Million
Q3 2023 Oct 27, 2023	SELL	$218.65 - $271.46 $495,898 - $615,671	-2,268 Reduced 5.09%	42,294 $11.4 Million
Q2 2023 Aug 03, 2023	BUY	$214.27 - $253.37 $161,559 - $191,040	754 Added 1.72%	44,562 $9.89 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $88,509 - $107,878	-392 Reduced 0.89%	43,808 $10.6 Million
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $432,179 - $549,135	-1,887 Reduced 4.09%	44,200 $11.6 Million
Q3 2022 Nov 09, 2022	SELL	$224.46 - $253.15 $370,807 - $418,203	-1,652 Reduced 3.46%	46,087 $10.4 Million
Q2 2022 Aug 02, 2022	BUY	$230.71 - $256.74 $2.77 Million - $3.08 Million	12,014 Added 33.63%	47,739 $11.6 Million
Q1 2022 May 10, 2022	SELL	$219.27 - $242.57 $2.12 Million - $2.34 Million	-9,649 Reduced 21.27%	35,725 $8.64 Million
Q4 2021 Feb 09, 2022	SELL	$198.88 - $227.6 $164,076 - $187,770	-825 Reduced 1.79%	45,374 $10.2 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $473,786 - $555,098	-2,232 Reduced 4.61%	46,199 $9.82 Million
Q3 2021 Nov 09, 2021	BUY	$212.27 - $248.7 $4.3 Million - $5.04 Million	20,246 Added 71.83%	48,431 $10.3 Million
Q2 2021 Aug 09, 2021	SELL	$233.58 - $259.14 $86,424 - $95,881	-370 Reduced 1.3%	28,185 $6.87 Million
Q1 2021 May 11, 2021	SELL	$221.91 - $258.6 $44,160 - $51,461	-199 Reduced 0.69%	28,555 $7.1 Million
Q4 2020 Feb 11, 2021	SELL	$216.38 - $257.67 $44,790 - $53,337	-207 Reduced 0.71%	28,754 $6.61 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $281,110 - $312,618	-1,198 Reduced 3.97%	28,961 $7.36 Million
Q2 2020 Jul 31, 2020	SELL	$197.81 - $242.74 $7,121 - $8,738	-36 Reduced 0.12%	30,159 $7.11 Million
Q1 2020 May 05, 2020	SELL	$182.24 - $241.7 $210,669 - $279,405	-1,156 Reduced 3.69%	30,195 $6.12 Million
Q4 2019 Jan 07, 2020	SELL	$189.21 - $243.2 $72,467 - $93,145	-383 Reduced 1.21%	31,351 $7.56 Million
Q3 2019 Oct 23, 2019	BUY	$174.11 - $208.62 $13,580 - $16,272	78 Added 0.25%	31,734 $6.14 Million
Q2 2019 Aug 05, 2019	BUY	$166.7 - $195.41 $10,835 - $12,701	65 Added 0.21%	31,656 $0
Q1 2019 Apr 26, 2019	SELL	$180.87 - $203.88 $112,501 - $126,813	-622 Reduced 1.93%	31,591 $0
Q4 2018 Feb 11, 2019	SELL	$178.4 - $208.25 $44,778 - $52,270	-251 Reduced 0.77%	32,213 $6.27 Million
Q3 2018 Nov 05, 2018	BUY	$185.29 - $208.89 $4.35 Million - $4.9 Million	23,468 Added 260.87%	32,464 $0
Q3 2018 Nov 05, 2018	SELL	$185.29 - $208.89 $4.51 Million - $5.09 Million	-24,363 Reduced 73.03%	8,996 $0
Q2 2018 Aug 07, 2018	SELL	$166.05 - $186.51 $37,693 - $42,337	-227 Reduced 0.68%	33,359 $0
Q1 2018 May 02, 2018	SELL	$169.43 - $198.0 $114,026 - $133,254	-673 Reduced 1.96%	33,586 $0
Q4 2017 Jan 25, 2018	SELL	$168.79 - $188.59 $44,054 - $49,221	-261 Reduced 0.76%	34,259 $0
Q3 2017 Nov 09, 2017	BUY	$167.29 - $191.0 $43,160 - $49,278	258 Added 0.75%	34,520 $0
Q2 2017 Aug 14, 2017	BUY	N/A	34,262	34,262 $0

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.

Account

First Horizon Advisors, Inc. Amgen Inc Transaction History